Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 17/20 | 0.64 |
| ▸ | HSP90AB1 | P08238 | 8/20 | 0.64 |
| ▸ | HSP90B1 | P14625 | 4/20 | 0.58 |
| ▸ | HDAC8 | Q9BY41 | 8/20 | 0.56 |
| ▸ | HDAC3 | O15379 | 8/20 | 0.55 |
| ▸ | HDAC6 | Q9UBN7 | 8/20 | 0.55 |
| ▸ | HDAC1 | Q13547 | 7/20 | 0.55 |
| ▸ | HDAC4 | P56524 | 4/20 | 0.54 |
| ▸ | HDAC7 | Q8WUI4 | 4/20 | 0.54 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.54 |
| ▸ | HDAC10 | Q969S8 | 4/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 4/20 | 0.54 |
| ▸ | HDAC9 | Q9UKV0 | 4/20 | 0.54 |
| ▸ | HDAC5 | Q9UQL6 | 4/20 | 0.54 |
| ▸ | TRAP1 | Q12931 | 2/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL382696 | 0.91 | HSP90AA1 (0.63) | HSP90AA1HSP90AB1HSP90B1HDAC8HDAC3 | |
| SCHEMBL384542 | 0.91 | HSP90AA1 (0.63) | HSP90AA1HSP90AB1HSP90B1HDAC8HDAC3 | |
| SCHEMBL12802840 | 0.91 | HSP90AA1 (0.63) | HSP90AA1HSP90AB1HSP90B1HDAC8HDAC3 | |
| SCHEMBL384821 | 0.90 | HSP90AA1 (0.61) | HSP90AA1HSP90AB1HSP90B1HDAC8HDAC3 | |
| SCHEMBL12572459 | 0.89 | HSP90AA1 (0.60) | HSP90AA1HSP90AB1HSP90B1HDAC8HDAC3 | |
| Hydrochloric Acid SCHEMBL383284 | 0.89 | HSP90AA1 (0.60) | HSP90AA1HSP90AB1HSP90B1HDAC8HDAC3 | |
| SCHEMBL382495 | 0.89 | HSP90B1 (0.67) | HSP90AA1HSP90AB1HSP90B1HDAC8HDAC3 | |
| SCHEMBL383259 | 0.88 | HSP90AA1 (0.59) | HSP90AA1HSP90AB1HSP90B1HDAC8HDAC3 | |
| SCHEMBL12572543 | 0.86 | HSP90AA1 (0.57) | HSP90AA1HSP90AB1HSP90B1HDAC8HDAC3 | |
| SCHEMBL383886 | 0.85 | HSP90AA1 (0.71) | HSP90AA1HSP90AB1HSP90B1HDAC8HDAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2332909-A1 | Hydroxybenzamide derivatives and their use as inhibitors of HSP90 | Astex Therapeutics Limited (GB) | 2011-06-15 | — | — | EP | disclosed |
| US-20100216782-A1 | HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 | CHESSARI GIANNI | 2010-08-26 | — | — | US | disclosed |
| US-20100216782-A1 | HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 | CHESSARI GIANNI | 2010-08-26 | — | — | US | disclosed |
| WO-2008044041-A1 | PHARMACEUTICAL COMBINATIONS | ASTEX THERAPEUTICS LIMITED (GB) | 2008-04-17 | — | — | WO | disclosed |
| WO-2008044054-A2 | HYDROXY-SUBSTITUTED BENZOIC ACID AMIDE COMPOUNDS FOR USE IN THERAPY | ASTEX THERAPEUTICS LIMITED (GB) | 2008-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100216782-A1 | HYDROXYBENZAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF HSP90 | HSP90AB1, HSP90AB2P, HSP90AA1 | HSP90AA1 3/4885HSP90AB1 1/4885HSP90B1 5/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.